Search This Blog

Wednesday, January 30, 2019

Biogen price target raised to $341 from $328 at Leerink

Leerink analyst Geoffrey Porges raised his price target for Biogen to $341 from $328 following quarterly results. The analyst reiterates a Market Perform rating on the shares.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)